Varian Medical Systems (VAR) Earns News Impact Score of 0.19

News articles about Varian Medical Systems (NYSE:VAR) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Varian Medical Systems earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 45.6458535329806 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

Shares of Varian Medical Systems (NYSE:VAR) traded down $0.41 during trading on Tuesday, reaching $108.08. The company had a trading volume of 997,513 shares, compared to its average volume of 780,090. Varian Medical Systems has a one year low of $76.94 and a one year high of $114.09. The company has a market cap of $9,900.00, a PE ratio of 39.16, a P/E/G ratio of 3.30 and a beta of 0.68.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the Zacks’ consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The company had revenue of $739.00 million during the quarter, compared to the consensus estimate of $741.69 million. During the same period in the prior year, the business posted $1.03 earnings per share. Varian Medical Systems’s revenue for the quarter was down 1.1% compared to the same quarter last year. research analysts anticipate that Varian Medical Systems will post 4.11 EPS for the current fiscal year.

Several equities analysts have recently weighed in on VAR shares. Zacks Investment Research cut Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Friday, October 27th. Citigroup increased their price target on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a report on Monday, October 30th. Evercore ISI started coverage on Varian Medical Systems in a report on Wednesday, January 3rd. They set an “underperform” rating and a $100.00 price target on the stock. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a report on Sunday, October 29th. Finally, Royal Bank of Canada set a $105.00 price target on Varian Medical Systems and gave the company a “hold” rating in a report on Thursday, November 30th. Three analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company’s stock. Varian Medical Systems currently has a consensus rating of “Hold” and an average price target of $100.44.

In related news, EVP Kolleen T. Kennedy sold 931 shares of the firm’s stock in a transaction on Wednesday, October 18th. The stock was sold at an average price of $105.00, for a total value of $97,755.00. Following the transaction, the executive vice president now directly owns 27,531 shares of the company’s stock, valued at approximately $2,890,755. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Kolleen T. Kennedy sold 2,018 shares of the firm’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $111.97, for a total value of $225,955.46. Following the sale, the executive vice president now directly owns 27,749 shares in the company, valued at $3,107,055.53. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 112,816 shares of company stock worth $12,510,334. 0.78% of the stock is owned by insiders.

TRADEMARK VIOLATION WARNING: “Varian Medical Systems (VAR) Earns News Impact Score of 0.19” was reported by BBNS and is owned by of BBNS. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://baseballnewssource.com/markets/varian-medical-systems-var-receiving-somewhat-positive-news-coverage-accern-reports/1821436.html.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets
MLB Rumor: Pirates Discussing Andrew McCutchen with Mets


Leave a Reply

 
© 2006-2018 BBNS.